{"id":"best-oral-medication","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Hypotension"},{"rate":"null","effect":"Increased urination"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, the drug reduces glucose reabsorption in the kidneys, leading to increased glucose excretion in the urine. This results in decreased blood glucose levels. The drug also has effects on the cardiovascular system, including reduced blood pressure and decreased risk of hospitalization for heart failure.","oneSentence":"This drug works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:44:12.696Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT05639647","phase":"PHASE2","title":"Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections","status":"RECRUITING","sponsor":"Pfizer","startDate":"2023-04-18","conditions":"Gram-negative Bacterial Infections","enrollment":48},{"nctId":"NCT06925321","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2025-08-26","conditions":"Invasive Mold Infections","enrollment":219},{"nctId":"NCT06323044","phase":"NA","title":"MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2025-02-11","conditions":"Acute Lymphoblastic Leukemia","enrollment":150},{"nctId":"NCT03793361","phase":"PHASE2","title":"Phase II Study of Regorafenib as Maintenance Therapy","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2019-05-15","conditions":"Metastatic Soft Tissue Sarcoma","enrollment":127},{"nctId":"NCT07151378","phase":"PHASE3","title":"Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2025-10-27","conditions":"PARKINSON DISEASE (Disorder)","enrollment":150},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT06748482","phase":"NA","title":"Effect of Clinical Pharmacist Consultation on Pain Management","status":"COMPLETED","sponsor":"Anwar Mohsen Naji Bin Ali Alhaj","startDate":"2024-10-04","conditions":"Pacemaker, Pain Management","enrollment":60},{"nctId":"NCT07294677","phase":"PHASE1, PHASE2","title":"CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2026-03-17","conditions":"Leukemia, Lymphoma","enrollment":104},{"nctId":"NCT04667078","phase":"PHASE3","title":"REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts","status":"RECRUITING","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2022-03-02","conditions":"Acute Ischemia","enrollment":368},{"nctId":"NCT05537220","phase":"PHASE3","title":"Oral N-acetylcysteine for Retinitis Pigmentosa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-10-11","conditions":"Retinitis Pigmentosa","enrollment":485},{"nctId":"NCT06961019","phase":"NA","title":"Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients","status":"RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-08-25","conditions":"Type2 Diabetes Mellitus","enrollment":14},{"nctId":"NCT04217356","phase":"","title":"Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2020-08-05","conditions":"Myelofibrosis, High-Risk Cancer, Bone Marrow Cancer","enrollment":90},{"nctId":"NCT06939608","phase":"NA","title":"Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2025-04-28","conditions":"Pharmacokinetic Study in Healthy Volunteers","enrollment":36},{"nctId":"NCT03844620","phase":"PHASE2","title":"Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-01-29","conditions":"Refractory Colorectal Carcinoma, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8","enrollment":100},{"nctId":"NCT05614102","phase":"PHASE1","title":"A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2022-11-04","conditions":"Advanced Solid Tumors","enrollment":284},{"nctId":"NCT02296918","phase":"PHASE1","title":"Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL","status":"COMPLETED","sponsor":"Acerta Pharma BV","startDate":"2014-12-22","conditions":"Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia","enrollment":69},{"nctId":"NCT05611242","phase":"PHASE3","title":"Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial","status":"RECRUITING","sponsor":"Mercy Health Ohio","startDate":"2024-05-08","conditions":"Acute Ischemic Stroke","enrollment":404},{"nctId":"NCT04328805","phase":"PHASE4","title":"Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome.","status":"COMPLETED","sponsor":"Universidad Europea de Madrid","startDate":"2020-09-23","conditions":"Carpal Tunnel Syndrome, Ibuprofen, Pain Management","enrollment":123},{"nctId":"NCT04025203","phase":"PHASE4","title":"Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Francisco Unda Solano","startDate":"2019-08-01","conditions":"Carpal Tunnel Syndrome","enrollment":196},{"nctId":"NCT04285281","phase":"PHASE4","title":"Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Universidad Europea de Madrid","startDate":"2020-04-01","conditions":"Carpal Tunnel Syndrome","enrollment":126},{"nctId":"NCT04119739","phase":"PHASE4","title":"Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Francisco Unda Solano","startDate":"2020-04-14","conditions":"Carpal Tunnel Syndrome","enrollment":117},{"nctId":"NCT03991819","phase":"PHASE1","title":"Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-09-20","conditions":"Non-small Cell Carcinoma","enrollment":40},{"nctId":"NCT04209790","phase":"PHASE2","title":"Neoadjuvant Chemoradiation for Resectable Glioblastoma","status":"TERMINATED","sponsor":"Geisinger Clinic","startDate":"2020-04-01","conditions":"Glioblastoma, Surgery, High Grade Glioma","enrollment":2},{"nctId":"NCT05200442","phase":"PHASE1, PHASE2","title":"A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2022-08-22","conditions":"Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic","enrollment":53},{"nctId":"NCT05113641","phase":"NA","title":"Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)","status":"RECRUITING","sponsor":"Dylan MacKay","startDate":"2023-08-04","conditions":"Chronic Kidney Diseases, Metabolic Acidosis","enrollment":40},{"nctId":"NCT07153887","phase":"PHASE2","title":"Vebreltinib for Advanced or Metastatic CCS","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-30","conditions":"Clear Cell Sarcoma (CCS)","enrollment":30},{"nctId":"NCT07011056","phase":"PHASE3","title":"A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Chengdu Zenitar Biomedical Technology Co., Ltd","startDate":"2025-07-18","conditions":"Recurrent and Refractory Diffuse Large B-cell Lymphoma","enrollment":390},{"nctId":"NCT07177300","phase":"PHASE4","title":"Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-12-19","conditions":"Sickle Cell Anemia (HbSS), Sickle-β0-thalassemia (HbSβ0)","enrollment":50},{"nctId":"NCT06041204","phase":"NA","title":"Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism","status":"RECRUITING","sponsor":"Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy","startDate":"2021-05-06","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical Hypothyroidism, Female Infertility","enrollment":200},{"nctId":"NCT04132778","phase":"NA","title":"Digital Prevention of Asthma","status":"TERMINATED","sponsor":"Karolinska Institutet","startDate":"2019-10-14","conditions":"Asthma, Care Management, Patient","enrollment":331},{"nctId":"NCT06023641","phase":"PHASE2","title":"Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-03-13","conditions":"Rhabdomyosarcoma","enrollment":135},{"nctId":"NCT04879368","phase":"PHASE3","title":"RegoNivo vs Standard of Care Chemotherapy in AGOC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Australasian Gastro-Intestinal Trials Group","startDate":"2021-06-01","conditions":"Gastro-Oesophageal Cancer","enrollment":450},{"nctId":"NCT05230537","phase":"PHASE2","title":"A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-02-17","conditions":"Age-Related Macular Degeneration","enrollment":170},{"nctId":"NCT02213575","phase":"PHASE2","title":"Study 3: Minocycline Decreases Microglia Activation","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-03-05","conditions":"Hypertension","enrollment":5},{"nctId":"NCT02577926","phase":"PHASE2","title":"The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"RWTH Aachen University","startDate":"2015-10","conditions":"Polycythemia Vera (PV), Essential Thrombocythemia (ET)","enrollment":207},{"nctId":"NCT04504812","phase":"PHASE3","title":"A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-02-01","conditions":"Knee Osteoarthritis","enrollment":1937},{"nctId":"NCT03195699","phase":"PHASE1","title":"Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers","status":"COMPLETED","sponsor":"Tvardi Therapeutics, Incorporated","startDate":"2017-11-15","conditions":"Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer","enrollment":64},{"nctId":"NCT06776029","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Radiation-Induced Proctopathy","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-02-01","conditions":"Radiation Induced Proctitis","enrollment":20},{"nctId":"NCT02043678","phase":"PHASE3","title":"Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-03-30","conditions":"Prostatic Neoplasms","enrollment":806},{"nctId":"NCT05956314","phase":"PHASE1","title":"Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2023-03-06","conditions":"Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita","enrollment":18},{"nctId":"NCT03996772","phase":"PHASE3","title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-06-03","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":319},{"nctId":"NCT03314740","phase":"PHASE2","title":"Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2017-06-12","conditions":"Ovarian Neoplasms","enrollment":123},{"nctId":"NCT03096054","phase":"PHASE1","title":"A CR-UK Phase I Trial of LY3143921","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cancer Research UK","startDate":"2017-06-21","conditions":"A. Colorectal Cancer, B. High Grade Serous Ovarian Cancer, C. Non Small-cell Lung Cancer (squamous Cell Variant)","enrollment":69},{"nctId":"NCT03201445","phase":"PHASE2","title":"Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflammatory Bowel Disease","status":"TERMINATED","sponsor":"Galapagos NV","startDate":"2017-07-11","conditions":"Inflammatory Bowel Disease","enrollment":139},{"nctId":"NCT01607957","phase":"PHASE3","title":"Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies","status":"COMPLETED","sponsor":"Taiho Oncology, Inc.","startDate":"2012-06-17","conditions":"Colorectal Cancer","enrollment":800},{"nctId":"NCT02500043","phase":"PHASE3","title":"Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer","status":"COMPLETED","sponsor":"Taiho Oncology, Inc.","startDate":"2016-02-24","conditions":"Refractory Metastatic Gastric Cancer","enrollment":507},{"nctId":"NCT06468215","phase":"NA","title":"Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07","conditions":"Carcinoma, Endometrioid, Fertility Preservation","enrollment":16},{"nctId":"NCT04085315","phase":"PHASE1","title":"Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer","status":"RECRUITING","sponsor":"Collin Blakely","startDate":"2019-11-12","conditions":"Lung Cancer Metastatic, EGFR Gene Mutation","enrollment":38},{"nctId":"NCT04655118","phase":"PHASE2","title":"Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis","status":"RECRUITING","sponsor":"Telios Pharma, Inc.","startDate":"2020-10-22","conditions":"Myelofibrosis, Indolent Systemic Mastocytosis","enrollment":121},{"nctId":"NCT03926195","phase":"PHASE2","title":"Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis","status":"COMPLETED","sponsor":"Galapagos NV","startDate":"2019-05-28","conditions":"Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis","enrollment":109},{"nctId":"NCT04665973","phase":"NA","title":"Effect of an Oral Therapeutic Patient Education Session on Physical Activity in Patients With Cancer","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2020-12-07","conditions":"Cancer","enrollment":98},{"nctId":"NCT03278509","phase":"PHASE4","title":"Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2017-09-11","conditions":"Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction","enrollment":5000},{"nctId":"NCT06232473","phase":"PHASE4","title":"Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-01-01","conditions":"Functional Disorder","enrollment":424},{"nctId":"NCT03572634","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL","status":"TERMINATED","sponsor":"Sumitomo Pharma America, Inc.","startDate":"2019-06-10","conditions":"Chronic Lymphocytic Leukemia, CLL, SLL","enrollment":3},{"nctId":"NCT04416334","phase":"PHASE3","title":"PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS","status":"COMPLETED","sponsor":"Instituto de Investigación Marqués de Valdecilla","startDate":"2020-08-19","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":70},{"nctId":"NCT05762146","phase":"PHASE2","title":"Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE","status":"UNKNOWN","sponsor":"Maastricht University","startDate":"2022-09-05","conditions":"Ischemic Stroke, Acute","enrollment":28},{"nctId":"NCT05569538","phase":"PHASE2","title":"Bomedemstat (IMG-7289) Plus Ruxolitinib for Myelofibrosis","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-12-01","conditions":"Myelofibrosis","enrollment":40},{"nctId":"NCT05865665","phase":"","title":"Registry Of Best Up-titration STrategies in Acute Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Heart Initiative","startDate":"2023-06","conditions":"Acute Heart Failure","enrollment":5000},{"nctId":"NCT04622865","phase":"PHASE2","title":"Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19","status":"UNKNOWN","sponsor":"AB Science","startDate":"2020-06-01","conditions":"SARS-CoV 2, COVID-19, Coronavirus Disease 2019","enrollment":200},{"nctId":"NCT05623904","phase":"NA","title":"Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2022-10-14","conditions":"Carotid Artery Stenting, Carotid Endarterectomy, Best Medical Treatment","enrollment":1056},{"nctId":"NCT04757857","phase":"PHASE4","title":"COVID-19 Antithrombotic Rivaroxaban Evaluation","status":"TERMINATED","sponsor":"Hospital Alemão Oswaldo Cruz","startDate":"2020-09-29","conditions":"COVID-19","enrollment":660},{"nctId":"NCT04333914","phase":"PHASE2","title":"Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2020-04-15","conditions":"SARS-CoV-2 (COVID-19) Infection, Advanced or Metastatic Hematological or Solid Tumor","enrollment":19},{"nctId":"NCT04402658","phase":"NA","title":"Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?","status":"WITHDRAWN","sponsor":"Norwegian School of Sport Sciences","startDate":"2022-08-01","conditions":"Sports Drug Abuse","enrollment":""},{"nctId":"NCT04042077","phase":"PHASE3","title":"Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections","status":"TERMINATED","sponsor":"Menarini Group","startDate":"2019-09-25","conditions":"Surgical Site Infection","enrollment":268},{"nctId":"NCT04043143","phase":"NA","title":"24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-10-24","conditions":"Opioid Use","enrollment":57},{"nctId":"NCT02356757","phase":"NA","title":"Preventing Amputations by Tailored Risk-based Intervention to Optimize Therapy","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2015-08-24","conditions":"Diabetes, Foot Ulcer","enrollment":406},{"nctId":"NCT04982900","phase":"PHASE2","title":"Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2021-10-01","conditions":"Multiple Primary Lung Cancers","enrollment":138},{"nctId":"NCT05014373","phase":"PHASE3","title":"Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19","status":"UNKNOWN","sponsor":"University of the Philippines","startDate":"2020-10-12","conditions":"Covid19","enrollment":144},{"nctId":"NCT01352715","phase":"PHASE3","title":"Study of Options for Second-Line Effective Combination Therapy (SELECT)","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2012-03-13","conditions":"HIV-1 Infection","enrollment":515},{"nctId":"NCT04346147","phase":"PHASE2","title":"Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19","status":"UNKNOWN","sponsor":"Hospital Universitario de Fuenlabrada","startDate":"2020-05-07","conditions":"COVID-19 Pneumonia","enrollment":168},{"nctId":"NCT03490123","phase":"PHASE4","title":"Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-04-16","conditions":"Yaws","enrollment":56000},{"nctId":"NCT04175899","phase":"NA","title":"Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia","status":"UNKNOWN","sponsor":"Ministry of Health, Malaysia","startDate":"2019-12-10","conditions":"Solid Tumor, Adult","enrollment":106},{"nctId":"NCT04183478","phase":"PHASE2, PHASE3","title":"The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2017-09-26","conditions":"Pancreatic Cancer","enrollment":600},{"nctId":"NCT04529148","phase":"PHASE4","title":"The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression","status":"UNKNOWN","sponsor":"Wanbangde Pharmaceutical Group Co., LTD","startDate":"2020-09-20","conditions":"Stable Angina Pectoris Associated With Depression","enrollment":72},{"nctId":"NCT00712270","phase":"PHASE4","title":"Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia","status":"TERMINATED","sponsor":"Kettering Health Network","startDate":"2005-04","conditions":"Schizophrenia","enrollment":21},{"nctId":"NCT04107480","phase":"PHASE4","title":"PRolaCT - Three Prolactinoma RCTs","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2019-06-21","conditions":"Prolactinoma, Prolactin-Producing Pituitary Tumor","enrollment":880},{"nctId":"NCT03415126","phase":"PHASE1","title":"A Study of ASN007 in Patients With Advanced Solid Tumors","status":"COMPLETED","sponsor":"Asana BioSciences","startDate":"2018-01-19","conditions":"Cancer, Malignancy, Neoplasia","enrollment":49},{"nctId":"NCT02196688","phase":"PHASE2","title":"Study of Fruquintinib in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Hutchison Medipharma Limited","startDate":"2014-04","conditions":"Colorectal Cancer","enrollment":71},{"nctId":"NCT04242927","phase":"PHASE2","title":"A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2020-03-09","conditions":"Hand-Foot Skin Reaction (HFSR)","enrollment":36},{"nctId":"NCT02314819","phase":"PHASE3","title":"A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)","status":"COMPLETED","sponsor":"Hutchison Medipharma Limited","startDate":"2014-12","conditions":"Colorectal Cancer","enrollment":416},{"nctId":"NCT03595709","phase":"PHASE3","title":"Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan","status":"COMPLETED","sponsor":"Yu-Jay Corp.","startDate":"2018-12-06","conditions":"HIV Infections","enrollment":50},{"nctId":"NCT04242758","phase":"PHASE4","title":"Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy","status":"UNKNOWN","sponsor":"University of Pisa","startDate":"2019-06-04","conditions":"Renal Function Disorder, Glucose Metabolism Disorders","enrollment":30},{"nctId":"NCT03373422","phase":"PHASE2","title":"A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best","status":"TERMINATED","sponsor":"Bayer","startDate":"2017-11-30","conditions":"Endometriosis","enrollment":121},{"nctId":"NCT02008318","phase":"PHASE2, PHASE3","title":"A Study of Galunisertib in Participants With Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2014-03","conditions":"Myelodysplastic Syndromes","enrollment":43},{"nctId":"NCT02049476","phase":"PHASE4","title":"Study of the Effectiveness of Ozurdex for the Control of Uveitis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-01","conditions":"Uveitis, Intermediate, Uveitis, Posterior","enrollment":20},{"nctId":"NCT03990935","phase":"NA","title":"Remineralization Potential of Ginger and Rosemary Herbals Versus Sodium Fluoride in Treatment of White Spot Lesions","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-07","conditions":"White Spot Lesions","enrollment":60},{"nctId":"NCT01358734","phase":"PHASE2","title":"A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Celgene","startDate":"2012-04-27","conditions":"Acute Myeloid Leukemia, Acute Myelogenous Leukemia","enrollment":88},{"nctId":"NCT01641367","phase":"PHASE4","title":"A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2013-02-22","conditions":"HIV-1 Infection","enrollment":545},{"nctId":"NCT01342692","phase":"PHASE2","title":"Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2011-06","conditions":"MDS","enrollment":320},{"nctId":"NCT01210495","phase":"PHASE2","title":"Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Pfizer","startDate":"2010-12-06","conditions":"Hepatocellular Carcinoma","enrollment":224},{"nctId":"NCT03188211","phase":"NA","title":"E-learning to Improve Oral Anticoagulant Use in Hospitalized Older People With AF","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2017-09-01","conditions":"Simulation Training, Anticoagulant Drugs, Elderly","enrollment":247},{"nctId":"NCT01845701","phase":"PHASE3","title":"Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2010-03","conditions":"Malaria","enrollment":720},{"nctId":"NCT01985126","phase":"PHASE2","title":"An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2013-09-27","conditions":"Multiple Myeloma","enrollment":124},{"nctId":"NCT03474146","phase":"NA","title":"Comparative Evaluation of Antiplaque and Antigingivitis Efficacy of Ocimum Sanctum (Tulsi) Extract","status":"COMPLETED","sponsor":"Government College of Dentistry, Indore","startDate":"2017-04-12","conditions":"Periodontal Diseases, Gingivitis, Periodontitis","enrollment":90},{"nctId":"NCT01032239","phase":"PHASE4","title":"SISTERS: Spasticity In Stroke Study - Randomized Study","status":"COMPLETED","sponsor":"MedtronicNeuro","startDate":"2009-11","conditions":"Severe Spasticity","enrollment":61},{"nctId":"NCT01220895","phase":"PHASE2","title":"Alternate Donor Study of Pre-Emptive Cellular Therapy","status":"COMPLETED","sponsor":"Cell Medica Ltd","startDate":"2010-10","conditions":"Cytomegalovirus Infection","enrollment":52},{"nctId":"NCT01077908","phase":"PHASE3","title":"Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study","status":"COMPLETED","sponsor":"Cell Medica Ltd","startDate":"2008-07","conditions":"Cytomegalovirus Infection","enrollment":89},{"nctId":"NCT02300558","phase":"PHASE3","title":"Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2014-12-17","conditions":"Long QT Syndrome Type 3","enrollment":41},{"nctId":"NCT02397369","phase":"NA","title":"Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai","status":"UNKNOWN","sponsor":"Tata Memorial Hospital","startDate":"2015-03","conditions":"Compliance, Tobacco Use Cessation","enrollment":4000},{"nctId":"NCT00932152","phase":"PHASE2","title":"Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2010-09","conditions":"Non-small Cell Lung Cancer, Postmenopausal Women","enrollment":3}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":116,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Best oral medication","genericName":"Best oral medication","companyName":"University Hospital Tuebingen","companyId":"university-hospital-tuebingen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. Used for Type 2 diabetes, Heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}